BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E
197 results:

  • 1. Identification and validation of anoikis-related genes to clarify the prognosis and immune mechanisms of patients with low-grade glioma.
    Wang J; Liu Y; Qian M; Xu W; Chen J; Deng Y; Luo R; Chen J; Jia W; Liu L; Tian C
    Biochem Biophys Res Commun; 2024 Jun; 711():149894. PubMed ID: 38603834
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Comprehensive genomic profiling to identify actionable alterations for breast cancer brain metastases in the Chinese population.
    Lu Q; Wang N; Jiang K; Zhou H; Zhang P; Zhang J; Wang S; Sun P; Xu F
    ESMO Open; 2024 Mar; 9(3):102389. PubMed ID: 38460250
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Radiomic profiling for insular diffuse glioma stratification with distinct biologic pathway activities.
    Duan W; Wang Z; Ma Z; Zheng H; Li Y; Pei D; Wang M; Qiu Y; Duan M; Yan D; Ji Y; Cheng J; Liu X; Zhang Z; Yan J
    Cancer Sci; 2024 Apr; 115(4):1261-1272. PubMed ID: 38279197
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Regnase-2 inhibits glioblastoma cell proliferation.
    Sowinska W; Wawro M; Kochan J; Solecka A; Polak J; Kwinta B; Kasza A
    Sci Rep; 2024 Jan; 14(1):1574. PubMed ID: 38238463
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Long-Term Intracranial Outcomes With Combination Dual Immune-Checkpoint Blockade and Stereotactic Radiosurgery in Patients With Melanoma and Non-Small Cell Lung cancer brain Metastases.
    Vaios EJ; Shenker RF; Hendrickson PG; Wan Z; Niedzwiecki D; Winter SF; Shih HA; Dietrich J; Wang C; Salama AKS; Clarke JM; Allen K; Sperduto P; Mullikin T; Kirkpatrick JP; Floyd SR; Reitman ZJ
    Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1507-1518. PubMed ID: 38097090
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinical and Molecular Characteristics of Gonadotroph Pituitary Tumors According to the WHO Classification.
    Carbonara F; Feola T; Gianno F; Polidoro MA; Di Crescenzo RM; Arcella A; De Angelis M; Morace R; de Alcubierre D; Esposito V; Giangaspero F; Jaffrain-Rea ML
    Endocr Pathol; 2024 Mar; 35(1):1-13. PubMed ID: 38095839
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting.
    Rautajoki KJ; Jaatinen S; Hartewig A; Tiihonen AM; Annala M; Salonen I; Valkonen M; Simola V; Vuorinen EM; Kivinen A; Rauhala MJ; Nurminen R; Maass KK; Lahtela SL; Jukkola A; Yli-Harja O; Helén P; Pajtler KW; Ruusuvuori P; Haapasalo J; Zhang W; Haapasalo H; Nykter M
    Acta Neuropathol Commun; 2023 Nov; 11(1):176. PubMed ID: 37932833
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Correlation of brain Metastasis Genomic Alterations with Preoperative Imaging Features.
    Uggerly ASV; Cummins DD; Nguyen MP; Saggi S; Aghi MK; Morshed RA
    World Neurosurg; 2024 Jan; 181():e475-e482. PubMed ID: 37879437
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. FLNA expression modulates pathological markers of pituitary neuroendocrine tumours.
    Toledo J; Perez PA; Zanetti M; Díaz-Torga G; Mukdsi JH; Gutierrez S
    J Endocrinol; 2024 Jan; 260(1):. PubMed ID: 37855268
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. GTF2E2 downregulated by miR-340-5p inhibits the malignant progression of glioblastoma.
    Qiao X; Chen Y; Wang Z; Peng N; Niu W; Hou S; Wu J; Ji Y; Niu C; Cheng C
    Cancer Gene Ther; 2023 Dec; 30(12):1702-1714. PubMed ID: 37845349
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Differentiating brain metastasis from glioblastoma by time-dependent diffusion MRI.
    Kamimura K; Kamimura Y; Nakano T; Hasegawa T; Nakajo M; Yamada C; Akune K; Ejima F; Ayukawa T; Ito S; Nagano H; Takumi K; Nakajo M; Uchida H; Tabata K; Iwanaga T; Imai H; Feiweier T; Yoshiura T
    Cancer Imaging; 2023 Aug; 23(1):75. PubMed ID: 37553578
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Multiomics analyses reveal
    Zheng C; Wei Y; Zhang Q; Sun M; Wang Y; Hou J; Zhang P; Lv X; Su D; Jiang Y; Gumin J; Sahni N; Hu B; Wang W; Chen X; McGrail DJ; Zhang C; Huang S; Xu H; Chen J; Lang FF; Hu J; Chen Y
    Sci Adv; 2023 Aug; 9(31):eadf3984. PubMed ID: 37540752
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A novel risk signature for predicting brain metastasis in patients with lung adenocarcinoma.
    Zhao Y; Gu S; Li L; Zhao R; Xie S; Zhang J; Zhou R; Tu L; Jiang L; Zhang S; Ma S
    Neuro Oncol; 2023 Dec; 25(12):2207-2220. PubMed ID: 37379245
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A review on the role of SNHG8 in human disorders.
    Ghafouri-Fard S; Harsij A; Hussen BM; Taheri M; Ayatollahi SA
    Pathol Res Pract; 2023 May; 245():154458. PubMed ID: 37043963
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. MRI features of pediatric atypical teratoid rhabdoid tumors and medulloblastomas of the posterior fossa.
    Wu HW; Wu CH; Lin SC; Wu CC; Chen HH; Chen YW; Lee YY; Chang FC
    Cancer Med; 2023 May; 12(9):10449-10461. PubMed ID: 36916326
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Integrative analysis of small non-coding RNAs predicts a piRNA/miRNA-ccnd1/BRAF/HRH1/ATXN3 regulatory circuit that drives oncogenesis in glioblastoma.
    Nayak R; Chattopadhyay T; Gupta P; Mallick B
    Mol Omics; 2023 Mar; 19(3):252-261. PubMed ID: 36688618
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A temporal in vivo catalog of chromatin accessibility and expression profiles in pineoblastoma reveals a prevalent role for repressor elements.
    Idriss S; Hallal M; El-Kurdi A; Zalzali H; El-Rassi I; Ehli EA; Davis CM; Chung PED; Gendoo DMA; Zacksenhaus E; Saab R; Khoueiry P
    Genome Res; 2023 Feb; 33(2):269-282. PubMed ID: 36650051
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Radiotherapy and Immunotherapy in Melanoma brain Metastases.
    Anvari A; Sasanpour P; Kheradmardi MR
    Hematol Oncol Stem Cell Ther; 2023 Jan; 16(1):1-20. PubMed ID: 36634277
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Contribution of tumor characteristics and surgery-related factors to symptomatic hydrocephalus after posterior fossa tumor resection: a single-institution experience.
    Zhang N; Zhang D; Sun J; Sun H; Ge M
    J Neurosurg Pediatr; 2023 Feb; 31(2):99-108. PubMed ID: 36446021
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. TNM Staging and Overall Survival in Patients With Pheochromocytoma and Sympathetic Paraganglioma.
    Jimenez C; Ma J; Roman Gonzalez A; Varghese J; Zhang M; Perrier N; Habra MA; Graham P; Waguespack SG
    J Clin Endocrinol Metab; 2023 Apr; 108(5):1132-1142. PubMed ID: 36433823
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 10.